Skip to main content
VIYASH SCIENTIFIC LIMITED logo

VIYASH SCIENTIFIC LIMITED — Investor Relations & Filings

Ticker · VIYASH ISIN · INE807F01027 LEI · 335800SXM7D3VSHF2X07 BSE.NS Manufacturing
Open in API
Filings indexed 1,424 across all filing types
Latest filing 2025-05-08 Board/Management Inform…
Country IN India
Listing BSE.NS VIYASH

About VIYASH SCIENTIFIC LIMITED

https://www.viyash.com

Viyash Scientific Limited is an integrated pharmaceutical platform specializing in the development and manufacturing of Active Pharmaceutical Ingredients (APIs), advanced intermediates, and finished dosage forms. The organization operates a network of manufacturing facilities supported by robust research and development capabilities, focusing on complex chemistry and niche therapeutic segments. Its core business activities encompass the entire pharmaceutical value chain, from process development and scale-up to commercial-scale production. The company provides integrated solutions to global partners, leveraging its technical expertise in chemical synthesis and commitment to international quality standards. By maintaining a focus on operational excellence and innovation, the company serves as a strategic partner in the global healthcare supply chain, delivering high-quality medicinal components and formulations.

Recent filings

Filing Released Lang Actions
Sequent Scientific Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2025 ,inter alia, to consider and approve Pursuant to Regulation 29(1) ....
Board/Management Information Classification · 95% confidence The document is a formal notice addressed to stock exchanges about an upcoming Board Meeting scheduled for May 20, 2025. The purpose of the meeting includes considering and approving the audited financial results for the quarter and year ended March 31, 2025, and recommending dividends. It also mentions the closure of the trading window around the announcement date. The document is an intimation of a Board Meeting and not the financial results themselves or any detailed report. It is a regulatory announcement about a board meeting under SEBI regulations, specifically Regulation 29(1). The document length is short (2234 characters), and it does not contain financial data or detailed reports. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of board meetings and related management information.
2025-05-08 English
General Updates
Capital/Financing Update Classification · 95% confidence The document is a disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the allotment of shares in a subsidiary company. It details the acquisition of shares in a step-down subsidiary, including the nature of the transaction, cost, percentage of shareholding, and background information about the acquired entity. The document is an announcement of a capital investment transaction and not a full financial report, earnings release, or management discussion. It does not contain financial statements or detailed financial analysis but rather regulatory disclosure about a capital transaction. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is about 5973 characters, which is sufficient for a detailed announcement but not a full report. Hence, the classification is CAP with high confidence.
2025-04-30 English
Disclosure under regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulation , 2015.
Capital/Financing Update Classification · 95% confidence The document is a disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the allotment of shares in a subsidiary company. It details the acquisition of shares in a step-down subsidiary, including the nature of the transaction, cost, percentage of shareholding, and background information about the acquired entity. The document is an announcement of a capital investment transaction and not a full financial report, earnings release, or management discussion. It does not contain financial statements or detailed financial analysis but rather regulatory disclosure about a capital transaction. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is about 5973 characters, which is sufficient for a detailed announcement but not a full report. Hence, the classification is CAP with high confidence.
2025-04-30 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing them about the schedule of meetings with analysts and institutional investors. It references compliance with SEBI regulations about disclosure requirements. The content is about announcing an upcoming investor meeting and explicitly states that no unpublished price sensitive information will be shared. The document is short (1991 characters) and does not contain any financial data, results, or detailed presentations. It is not a report or earnings release but an announcement of an event related to investor relations. Therefore, it fits best under the category of Investor Presentation (IP) as it relates to investor meetings and presentations, although the actual presentation is not included. However, since it is only an intimation of the schedule of meetings and not the presentation itself, it is more appropriate to classify it as a Regulatory Filing (RNS) because it is a general regulatory announcement about investor meetings without substantive financial content or presentation materials.
2025-04-24 English
Intimation of Schedule of Analysts / Institutional Investor Meeting
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing them about the schedule of upcoming meetings with analysts and institutional investors. It references compliance with SEBI regulations and explicitly states that no unpublished price sensitive information will be shared. The content is an announcement of a meeting schedule rather than a financial report, earnings release, or detailed investor presentation. The document length is short (1991 characters), and it does not contain financial data or detailed analysis. Therefore, it is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance-related disclosures that do not fit other categories.
2025-04-24 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming details of securities dematerialized/rematerialized for the quarter ended March 31, 2025. It is addressed to stock exchanges and signed by the company secretary and the registrar. The document is short (2367 characters) and serves as a compliance certificate rather than a financial report or detailed filing. It does not contain financial statements, management discussion, or audit information. It is a regulatory compliance certificate related to shareholding and securities dematerialization, which fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance document.
2025-04-08 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.